创陞融资_Providing professional financial news and data related to 创陞融资, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Finance
JIANGXI BIOLOGY(06915.HK): Veterinary Tetanus Antitoxin Production Line Officially Put into Operation
Finance
Anker Innovations (00668.HK): H-shares Included in Stock Connect Eligible Securities List
Finance
IMPACT Therapeutics(07630.HK): IMP3201 Nominated as Preclinical Candidate Compound, a Dual-Loaded ADC Targeting CEACAM5
Finance
JIANGXI BIOLOGY(06915.HK): Stabilisation Period Concludes, Over-Allotment Option Lapses
Finance
UBTECH Robotics (09880.HK): Purchase of Shares from the Market Pursuant to H-share Incentive Scheme
Finance
Akeso(09926.HK): Grant of Share Options and Restricted Share Units
Finance
Home Control (01747.HK): Signs Strategic Cooperation MOU with Articura on Indonesia Localized Healthcare AI
Finance
Jacobio Pharmaceuticals(01167.HK): First Patient Dosed in Phase IIa Clinical Trial of BET Inhibitor JAB-8263 for Rheumatoid Arthritis
Finance
Fosun Pharma (02196.HK): DM1001 Preparation Obtains Clinical Trial Approval
Finance
China Financial Services(00605.HK): Grants RMB 8.9 Million Loan to Client

Scan QR Code

Download App